• Microglia - from biology to pathology

    Microglia - from biology to pathology
    April 20-21, 2017 - Groningen, the Netherlands

    Read more ...  
  • ISNI SESSION - AAI 2017

    ISNI Session at the Immunology 2017 meeting

    Date: Monday, May 15, 2017
    Time: 10:15 AM - 12:15 PM

     
  • 1st CUBANNI

    First International Workshop of Cuban Network of Neuroimmunology

    Varadero, June 10-14, 2017

    Read more ...  
  • #AINIESNI2017

    XXVI AINI Congress and 16th ESNI Course

    June 26-30, 2017 - San Servolo, Venice, Italy

    Read more ...  
  • #ASNI2017

    2nd ASNI Course

    October 3-6, 2017 - Charlottesville (VA), USA

    Read more ...  
  • Regeneration

    November 16-18, 2017, Milan Italy

    Read more ...  

Baranzini

 

 

Professor In-Residence
Department of Neurology
University of California San Francisco (UCSF)

 

 

Sergio E. Baranzini is Professor In-Residence in the Department of Neurology at the University of California San Francisco (UCSF). He is also a member of the Graduate Program in Bioinformatics, the Institute for Human Genetics, and of the California Institute for quantitative Biology (QB3). He holds the Heidrich Friends and Family endowed chair in Neurology.

Dr. Baranzini earned his degrees in clinical biochemistry (1992) and PhD in human molecular genetics (1997) from the University of Buenos Aires, Argentina. Dr. Baranzini then moved to UCSF to specialize in the analysis of complex hereditary diseases, and focused his efforts on multiple sclerosis. His current research involves the large throughput analysis of samples from MS patients to characterize the activity of genes during different stages of the disease, differential response to treatment, and disease progression. In addition Dr. Baranzini collaborates with several interdisciplinary teams worldwide to integrate all the available knowledge obtained in different research domains in an approach known as systems biology. Dr. Baranzini's current research also involves immunological studies using the EAE model, sequencing the whole genomes and transcriptomes from patients with multiple sclerosis and developing bioinformatics tools to integrate this information with that coming from other high throughput technologies. More recently, he has started a research program that will study the effect of bacterial populations (microbiota) on MS susceptibility and progression.

Dr. Baranzini has published his research on MS in several top-tier journals like Science, Nature, PNAS, J Immunol, and PLos Biol. He is a member fo the American Association of Immunologists, and an elected member of the American Neurological Association and the International Society of Neuroimmunology. He is also a member of the Editorial Board of the MS Journal and Neurology in addition to serving as an ad-hoc reviewer for several other scientific publications in including Nature Medicine, PNAS, and the Am J Hum Genet. 

Joomla Template by Joomla51.com

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie policy